Hand Osteoarthritis
1
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
BioibericaDroglican
Marius PharmaceuticalsMetformin
ETSNeural mobilization
Clinical Trials (3)
Total enrollment: 552 patients across 3 trials
Primary Care Study With Chondroitin Sulfate and Glucosamine Hydrochloride in Hand Osteoarhritis
Start: Aug 2016Est. completion: Jul 2017330 patients
Phase 4Unknown
Metformin Treatment of Patients with Hand Osteoarthritis
Start: Jun 2024Est. completion: Apr 2026150 patients
Phase 3Recruiting
Manual Therapy for Hand Osteoarthritis
Start: Jul 2016Est. completion: Apr 201872 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
1 actively recruiting trials targeting 552 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.